A comparison of continuous glucose monitoring-measured time-in-range 70-180 mg/dL versus time-in-tight-range 70-140 mg/dL 2024

A scalable application of artificial intelligence-driven insulin titration program to transform type 2 diabetes management 2024

Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis 2024

Continuous glucose monitoring prediction of gestational diabetes mellitus and perinatal complications 2024

Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens 2024

Glycemic outcomes persist for up to 2 years in very young children with the Omnipod(®) 5 Automated Insulin Delivery System 2024

Impact of continuous glucose monitoring versus blood glucose monitoring to support a carbohydrate-restricted nutrition intervention in people with type 2 diabetes 2024

Long-term improvements in glycemic control with dexcom CGM use in adults with noninsulin-treated type 2 diabetes 2024

Time in range, time in tight range, and average glucose relationships are modulated by glycemic variability: identification of a glucose distribution model connecting glycemic parameters using real-world data 2024

Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes 2024

A comparison of continuous glucose monitoring estimated hemoglobin A1c in adults with type 1 or type 2 diabetes 2023

Assessment of the glucose management indicator using different sampling durations 2023

Discordance between glucose management indicator and glycated hemoglobin in people without diabetes 2023

Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial 2023

Increased derived time in range is associated with reduced risk of major adverse cardiovascular events, severe hypoglycemia, and microvascular events in type 2 diabetes: a post hoc analysis of DEVOTE 2023

Safety and glycemic outcomes during the MiniMed(TM) advanced hybrid closed-loop system pivotal trial in children and adolescents with type 1 diabetes 2023

The relationship between percent time <70 mg/dL and percent time <54 mg/dL measured by continuous glucose monitoring 2023

A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G 2022

Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes 2022

Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems 2022

Real-world evidence supporting Tandem Control-IQ Hybrid Closed-Loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations 2022

Safety and glycemic outcomes during the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in adolescents and adults with type 1 diabetes 2022

The optimal duration of a run-in period to initiate continuous glucose monitoring for a randomized trial 2022

Continuous glucose monitoring integration for remote diabetes management: virtual diabetes care with case studies 2021

First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes 2021

Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives 2021

Lost in translation: a disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion 2021

Real-world, patient-reported and clinic data from individuals with type 1 diabetes using the MiniMed 670G hybrid closed-loop system 2021

Remote application and use of real-time continuous glucose monitoring by adults with type 2 diabetes in a virtual diabetes clinic 2021

The digital/virtual diabetes clinic: the future Is now-recommendations from an international panel on diabetes digital technologies introduction 2021

Ultrarapid lispro demonstrates similar time in target range to lispro with a hybrid closed-loop system 2021

Ultra-rapid lispro improves postprandial glucose control and time in range in type 1 diabetes compared to lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy 2020

Current status and future directions for electronic point-of-care clinical decision support to improve diabetes management in primary care 2019

Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen 2019

Rationale and design for a GRADE substudy of continuous glucose monitoring 2019

State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018 2019

The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set 2019

Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control 2018

Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes 2017

Efficacy and safety of flexible versus fixed dosing intervals of insulin glargine 300 U/mL in people with type 2 diabetes 2016

Hypoglycemia in older adults with type 1 diabetes 2016

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP) 2013

Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study 2012

Can a tool that automates insulin titration be a key to diabetes management? 2012

Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial 2012

Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience 2011

Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter study 2011

International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece 2011

A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trial 2009

Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System 2009

Does availability of AIR insulin increase insulin use and improve glycemic control in patients with type 2 diabetes? 2009

Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time? 2009

Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, 2nd Annual Symposium, May 7-10, 2009, Berlin, Germany 2009

Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis 2008

Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control 2005

Making sense of glucose monitoring technologies: from SMBG to CGM 2005

Novel pattern identification through standardized data display using the ambulatory glucose profile (AGP) report [abstract] 2016

Continuous glucose monitoring for type 2 diabetes: how does it compare with type 1 diabetes [editorial]?.  24. 2022

Decreasing the burden of carbohydrate counting and meal announcement with automated insulin delivery, meal recognition, and autocorrection doses: a case study [review] 2024

Is it time to move beyond TIR to TITR? Real-world data from over 20,000 users of continuous glucose monitoring in patients with type 1 and type 2 diabetes [review] 2024

Primary care and diabetes technologies and treatments [review] 2024

Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking [review] 2023

Personalized glycated hemoglobin in diabetes management: closing the gap with glucose management indicator [review] 2023

Prevalence, cost, and burden of diabetic ketoacidosis [review] 2023

Primary care and diabetes technologies and treatments [review] 2023

Primary care and diabetes technologies and treatments [review] 2022

Comparison of second-generation basal insulin analogs: a review of the evidence from continuous glucose monitoring [review] 2021

Primary care and diabetes technologies and treatments [review] 2021

What's wrong with this picture? A critical review of current Centers for Medicare & Medicaid Services coverage criteria for continuous glucose monitoring [review] 2021

Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice [review] 2019

Clinical use of continuous glucose monitoring in adults with type 2 diabetes [review] 2017

Role of continuous glucose monitoring in clinical trials: recommendations on reporting [review] 2017

Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM) [review] 2008